Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment

Deep understanding of the SARS-CoV-2 effects on host molecular pathways is paramount for the discovery of early biomarkers of outcome of coronavirus disease 2019 (COVID-19) and the identification of novel therapeutic targets. In that light, we generated metabolomic data from COVID-19 patient blood u...

Descripción completa

Detalles Bibliográficos
Autores principales: Rendeiro, André F., Vorkas, Charles Kyriakos, Krumsiek, Jan, Singh, Harjot K., Kapadia, Shashi N., Cappelli, Luca Vincenzo, Cacciapuoti, Maria Teresa, Inghirami, Giorgio, Elemento, Olivier, Salvatore, Mirella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790058/
https://www.ncbi.nlm.nih.gov/pubmed/35095900
http://dx.doi.org/10.3389/fimmu.2021.809937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790058/
https://www.ncbi.nlm.nih.gov/pubmed/35095900
http://dx.doi.org/10.3389/fimmu.2021.809937

Ejemplares similares